Xvivo Perfusion AB
STO:XVIVO

Watchlist Manager
Xvivo Perfusion AB Logo
Xvivo Perfusion AB
STO:XVIVO
Watchlist
Price: 451.5 SEK 1.23% Market Closed
Market Cap: 14.2B SEK
Have any thoughts about
Xvivo Perfusion AB?
Write Note

Xvivo Perfusion AB
Short-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Xvivo Perfusion AB
Short-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Short-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Xvivo Perfusion AB
STO:XVIVO
Short-Term Debt
kr0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
O
OssDsign AB
STO:OSSD
Short-Term Debt
kr0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
D
Doxa AB
STO:DOXA
Short-Term Debt
kr0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bactiguard Holding AB
STO:BACTI B
Short-Term Debt
kr0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
V
Vimian Group AB
STO:VIMIAN
Short-Term Debt
€0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
S2Medical AB (publ)
STO:S2M
Short-Term Debt
kr0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Xvivo Perfusion AB
Glance View

Market Cap
14.2B SEK
Industry
Health Care

Xvivo Perfusion AB is a medical technology company. The company is headquartered in Goeteborg, Vastra Gotalands and currently employs 92 full-time employees. The company went IPO on 2012-10-08. The firm operates in two segments: Durable goods and Non-Durable goods. The Durable goods segment comprises sale and rental income from XVIVO Perfusion System (XPS) machines. The Non-Durable goods segment implies revenue from the sale of products and services that are solutions and disposable items. The Company’s product portfolio consists of Perfadex, STEEN Solution, XPS, XPS Disposable Kit, XVIVO Lung Cannula Set, XVIVO Organ Chamber, XPS PGM Disposable Sensors and Silicone Tubing Set. The firm markets its products in Europe, Asia, Middle East, and North & South America.

XVIVO Intrinsic Value
251.13 SEK
Overvaluation 44%
Intrinsic Value
Price

See Also

What is Xvivo Perfusion AB's Short-Term Debt?
Short-Term Debt
0 SEK

Based on the financial report for Sep 30, 2024, Xvivo Perfusion AB's Short-Term Debt amounts to 0 SEK.

Back to Top